Get the Daily Brief
Latest Biotech News
10x Genomics Acquires Scale Biosciences, Reports Revenue Dip
10x Genomics has agreed to acquire Scale Biosciences for $30 million upfront plus milestone payments, aiming to enhance its single-cell genomics platform with Scale’s innovative combinatorial...
PacBio Posts 7% Revenue Growth as Sequencing Demand Rises
Pacific Biosciences reported 7% year-over-year revenue growth in Q2 2025, totaling $39.8 million, driven primarily by consumables. Although instrument sales dipped slightly due to fewer...
Neonatal and Pediatric Imaging Innovations Enhance Diagnostic Precision
Recent research in pediatric radiology and neonatal medicine highlights advances in imaging and clinical approaches to enhance outcomes. Studies include: development of automated deep learning...
Novel Therapeutics and Molecular Targets in Cancer Research
Cutting-edge discoveries continue to deepen understanding of cancer biology and therapeutic opportunities. Highlights include: Genomic identification of follicular lymphoma subtypes with distinct...
Energy Storage and Battery Technology Breakthroughs
Researchers present significant advancements in materials and predictive models vital to energy storage technologies. Innovations include cathode nanoparticles enhancing zinc-ion battery...
Immunology and Microbiome Insights in Health and Disease
Emerging studies shed light on pivotal immunological mechanisms and microbiome interactions affecting disease progression and therapeutic potential. Investigations reveal the gut microbiome’s...
FDA Approves Jazz’s First Drug for Rare Pediatric Brain Cancer
Jazz Pharmaceuticals secured accelerated FDA approval for dordaviprone (Modeyso), the first systemic treatment targeting recurrent H3 K27M-mutant diffuse midline glioma, a rare and aggressive...
HHS Shifts Strategy, Cuts $500M from mRNA Vaccine Programs
In a controversial move, the U.S. Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., announced the termination of 22 BARDA-funded mRNA vaccine development contracts...
Strand Therapeutics Raises $153M to Advance mRNA Cancer Programs
Strand Therapeutics, a biotech developing programmable mRNA therapies aimed at orchestrating protein expression in tumor cells, closed a $153 million Series B financing round. Led by Kinnevik and...
10x Genomics Acquires Scale Biosciences to Boost Single-Cell Scale
10x Genomics expanded its single-cell technology portfolio by acquiring Scale Biosciences for an upfront $30 million payment plus performance-based milestones. Scale's split-pool combinatorial...
Novo Nordisk Faces Headwinds — Pipeline Pruning and Legal Challenges
Novo Nordisk announced discontinuation of multiple pipeline programs amid leadership transition and lower obesity drug sales growth forecasts. The company is confronting fierce competition from...
Bio-Techne’s Fiscal Growth Amid Macroeconomic and NIH Funding Concerns
Bio-Techne posted a 4 percent revenue increase in Q4 fiscal 2025 to $317 million, driven by strong demand in protein sciences and cell therapy workflow solutions despite a 1 percent decline in...
Iovance Biotherapeutics Restructures After Disappointing Cell Therapy Sales
Iovance announced a workforce reduction of less than 20 percent following a slow commercial uptake of its tumor infiltrating lymphocyte (TIL) therapy, Amtagvi, approved for advanced melanoma....
Quantum-Si Hits NIH Funding Roadblocks, Sees Revenue Dip
Proteomics technology developer Quantum-Si reported a 5 percent year-over-year revenue decline in Q2 2025, attributed primarily to funding constraints from the NIH that slowed capital sales...
Advancements in Pediatric Cancer Genomics Consortium Launch
Boston Children’s Hospital, Dana-Farber Cancer Institute, and Broad Clinical Labs have joined forces to establish BrightSeq, a clinical research consortium delivering integrated tissue and liquid...
HHS Halts $500M in mRNA Vaccine Funding Amid Political Shift
The U.S. Department of Health and Human Services (HHS) announced a sweeping cancellation of nearly $500 million in contracts for messenger RNA (mRNA) vaccine research under the Biomedical Advanced...
Strand Therapeutics Raises $153M for Programmable mRNA Cancer Drugs
Biotech startup Strand Therapeutics secured $153 million in Series B funding to advance its programmable mRNA therapeutics platform aimed at treating solid tumors. Founded on research from MIT,...
Eli Lilly’s Oral GLP-1 Obesity Pill Shows Modest Efficacy
Eli Lilly’s experimental oral GLP-1 receptor agonist, orforglipron, demonstrated up to 12.4% mean weight loss at 72 weeks in phase 3 trials involving adults with obesity or overweight status and...
Novo Nordisk Faces Leadership Change and Pipeline Challenges
Novo Nordisk is undergoing a leadership transition with Maziar Mike Doustdar set to assume CEO duties amid intensifying competition in the GLP-1 obesity and diabetes drug market. Sales growth has...
Merck’s Strategic Moves: Verona Buyout and Alzheimer’s Antibody Recommendation
Merck completed a $10 billion acquisition of Verona Pharma, acquiring the COPD drug ensifentrine after minimal competition during the bidding process. The acquisition consolidates Merck's presence...